LONG-TERM EFFICACY OF TRALOKINUMAB IN ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS

被引：0
|
作者：
Wollenberg, Andreas [1 ]
Paller, Amy S. [2 ]
Bewley, Anthony [3 ]
Cork, Michael [4 ,5 ]
Hong, Chih-Ho [6 ]
Soong, Weily [7 ]
Oland, Christian Bjerregard [8 ]
Taveira, Christian Moreira [8 ]
Gjerum, Le [8 ]
Blauvelt, Andrew [9 ]
机构：
[1] Ludwig Maximilian Univ Munich, Dept Dermatol & Allergy, Munich, Germany
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[3] Barts Hlth Nhs Trust, London, England
[4] Univ Sheffield, Sheffield Dermatol Res, Dept Infect Immun & Cardiovasc Dis, Sheffield, S Yorkshire, England
[5] Sheffield Teaching Hosp, Sheffield, S Yorkshire, England
[6] Univ British Columbia, Vancouver, BC, Canada
[7] Allervie Hlth Alabama Allergy & Asthma Ctr, Birmingham, AL USA
[8] Leo Pharma AS, Ballerup, Denmark
[9] Oregon Med Res Ctr, Portland, OR USA
来源：
ACTA DERMATO-VENEREOLOGICA | 2023年 / 103卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P10.12
引用
收藏
页码：54 / 54
页数：1
相关论文
共 50 条
  • [1] Long-term safety and efficacy of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: an interim analysis of ECZTEND
    Simpson, Eric
    Paller, Amy
    Wollenberg, Andreas
    Bewley, Anthony
    Cork, Michael
    Hong, Chih-Ho
    Soong, Weily
    Almgren, Peter
    Carlsson, Anna
    Blauvelt, Andrew
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB190 - AB190
  • [2] Stability of long-term therapeutic responses to tralokinumab in adults with moderate-to-severe atopic dermatitis
    Blauvelt, Andrew
    Hong, H. Chih-ho
    Peris, Ketty
    Katoh, Norito
    Tauber, Marie
    Ameen, Mahreen
    Gooderham, Melinda
    Oland, Christian Bjerregard
    Tindberg, Ann-Marie
    Gjerum, Le
    Reich, Kristian
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2024, 191 : 30 - 31
  • [3] Long-term tralokinumab therapy in moderate to severe atopic dermatitis
    Lorenz, Judith
    [J]. AKTUELLE DERMATOLOGIE, 2023, 49 (03) : 91 - 91
  • [4] Safety and Efficacy of Tralokinumab in Older Adults With Moderate-to-Severe Atopic Dermatitis
    Merola, Joseph F.
    Butler, Daniel C.
    Mark, Thomas
    Schneider, Shannon
    Kim, Yestle
    Abuabara, Katrina
    [J]. JAMA DERMATOLOGY, 2023, 159 (10) : 1119 - 1123
  • [5] Dupilumab provides long-term improvement in pruritus in children with severe atopic dermatitis and adolescents and adults with moderate-to-severe atopic dermatitis
    Cork, Michael J.
    Yosipovitch, Gil
    Silverberg, Jonathan I.
    Praestgaard, Amy
    Zhang, Haixin
    Wang, Zhixiao
    Rossi, Ana B.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 : 79 - 79
  • [6] Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
    Edwards, Steven J.
    Karner, Charlotta
    Jhita, Tracey
    Barton, Samantha
    Marceniuk, Gemma
    Yiu, Zenas Z. N.
    Wittmann, Miriam
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2024, 28 (04)
  • [7] A critical evaluation of suitability of tralokinumab for treatment of moderate-to-severe atopic dermatitis in adolescents and adults
    Pezzolo, Elena
    Sechi, Andrea
    Tartaglia, Jacopo
    Naldi, Luigi
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (03) : 255 - 266
  • [8] Efficacy and safety of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: results of the phase III ECZTRA 6 trial
    Paller, Amy
    Blauvelt, Andrew
    Soong, Weily
    Imafuku, Shinichi
    Hong, Chih-Ho
    Schuttelaar, Marie L. A.
    Amoudruz, Petra
    Kurbasic, Azra
    Soldbro, Lise
    Lophaven, Katja
    Cork, Michael
    Bewley, Anthony
    Simpson, Eric L.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 187 (03) : E90 - E91
  • [9] Long-term improvements observed in tralokinumab-treated patients with moderate-to-severe atopic dermatitis: an ECZTEND interim analysis
    Blauvelt, A.
    Lacour, J. -P.
    Toth, D.
    Laquer, V.
    Beissert, S.
    Wollenberg, A.
    Herranz, P.
    Pink, A.
    Peris, K.
    Fangel, S.
    Saeki, H.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E112 - E113
  • [10] Efficacy and safety of tralokinumab in adolescents with moderate-to-severe atopic dermatitis: results of the phase III ECZTRA 6 trial
    Paller, A.
    Blauvelt, A.
    Soong, W.
    Imafuku, S.
    Hong, C.
    Schuttelaar, M. L. A.
    Amoudruz, P.
    Kurbasic, A.
    Soldbro, L.
    Lophaven, K.
    Schneider, S.
    Cork, M.
    Bewley, A.
    Simpson, E. L.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E145 - E146
12345